Početna › Ulcerativni kolitis › Utah
Kliničke studije za Ulcerativni kolitis u državi Utah
7 studija za Ulcerativni kolitis traži sudionike na lokacijama u državi Utah.
Gradovi u državi Utah
Službeni tekst studije (engleski)
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
- Care Access-Ogden, Ogden
- Advanced Research Institute - South Ogden, Ogden
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 30. ruj 2026. · NCT06598943A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
- University of Utah Hospitals & Clinics, Salt Lake City
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT06979336A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- University of Utah, Salt Lake City
U tijeku regrutacijaFaza 3
Od 3 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT06663332LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- Care Access - Ogden, Ogden
U tijeku regrutacijaFaza 2
Od 18 do 80 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07186101A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
- University of Utah Health, Salt Lake City
U tijeku regrutacijaFaza 4
Od 18 do 65 godina · Oba spola · Ažurirano 21. ruj 2026. · NCT06095128An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Velocity Clinical Research, Salt Lake City - Site Number: 8400147, West Jordan
U tijeku regrutacijaFaza 3
Od 16 do 80 godina · Oba spola · Ažurirano 20. kol 2026. · NCT07184996Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
- University of Utah Health, Salt Lake City
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 7. kol 2026. · NCT05230173Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.